As of my last update in October 2023, STR-V-53, identified by the CAS number 2798954-66-0, is a chemical compound that has garnered attention in research contexts, particularly in the field of medicinal chemistry. While specific characteristics such as its molecular structure, physical properties, and biological activity may not be widely documented in public databases, compounds with similar nomenclature often exhibit properties that can include being a synthetic organic molecule with potential applications in pharmacology. Typically, such compounds may be evaluated for their efficacy, safety, and mechanism of action in biological systems. Researchers may investigate their solubility, stability, and reactivity under various conditions, as well as their interactions with biological targets. For precise and detailed information, including experimental data and specific applications, consulting specialized scientific literature or databases would be necessary, as the compound may be under investigation or not yet fully characterized in public resources.

STR-V-53

2798954-66-0: As of my last update in October 2023, STR-V-53, identified by the CAS number 2798954-66-0, is a chemical compound that has garnered attention in research contexts, particularly in the field of medicinal chemistry. While specific characteristics such as its molecular structure, physical properties, and biological activity may not be widely documented in public databases, compounds with similar nomenclature often exhibit properties that can include being a synthetic organic molecule with potential applications in pharmacology. Typically, such compounds may be evaluated for their efficacy, safety, and mechanism of action in biological systems. Researchers may investigate their solubility, stability, and reactivity under various conditions, as well as their interactions with biological targets. For precise and detailed information, including experimental data and specific applications, consulting specialized scientific literature or databases would be necessary, as the compound may be under investigation or not yet fully characterized in public resources.

STR-V-53, an HDAC inhibitor (IC50 in nM), increases histone acetylation in tumor cells by inhibiting these enzymes, thereby regulating gene expression. STR-V-53 inhibits tumor growth and induces apoptosis [1].

CAS 2798954-66-0

STR-V-53

STR-V-53

Ref: TM-T87447